TrialSite News offers this press release directly from Velocity Clinical Research as we are big fans of CEO Dr. Paul Evans and his vision to transcend the network model for a high-quality clinical investigator site operation grown via acquisition and organic activities with a focus on patient safety, quality, and performance.
Velocity Clinical Research is delighted to announce that its senior management team is expanding again this year. Melissa Holbrook joins the Velocity Clinical team as VP Operations and will be responsible for clinical operations at all of Velocity’s sites. Melissa comes to Velocity Clinical after 13 years at IQVIA, where she held positions of increasing responsibility in clinical operations and site management, most recently as VP, Design and Delivery Innovation.
Jeff Jensen hands over the site operations responsibilities to Melissa so he can turn his full attention to Velocity Clinical’s acquisition activity as Sr. VP, Corporate Development. Velocity Clinical is actively pursuing a number of acquisition targets and expects to significantly increase in size by the end of the year.
In preparation for rapid growth, Velocity Clinical has hired a new Director ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).